This statistic shows the amount of registrations of newly diagnosed cases of lung cancer in England in 2021, by age group and gender. In this year, almost four thousand cases were reported among men aged 70 to 74 years. It should be noted that the number of people in England in each age group varies and is therefore not necessarily a reflection of susceptibility to lung cancer.

In 2022, the incidence of lung cancer cases among those aged above 75 years of age in the European Union was ***** per 100,000 men and ***** per 100,000 women. The risk of developing lung cancer can increase by smoking, inhaling second hand smoke and exposure to asbestos

Mortality from lung cancer (ICD-10 C33-C34 equivalent to ICD-9 162). To reduce deaths from lung cancer. Legacy unique identifier: P00513

As of 2022, the age-standardized incidence rate of lung cancer among males in Polynesia was 54.7 per 100,000 population, the highest rate worldwide. The incidence rate of lung cancer among females was highest in Northern America. This statistic shows the age-standardized incidence rate of lung cancer worldwide as of 2022, by region and gender.

Summary statistics of average lung cancer incidence rates and average daily smokers in percentage in 8 U.S. geographic regions, 1999–2012.

Mortality from lung cancer, directly age-standardised rate, persons, under 75 years, 2004-08 (pooled) per 100,000 European Standard population by Local Authority by local deprivation quintile. Local deprivation quintiles are calculated by ranking small areas (Lower Super Output Areas (LSOAs)) within each Local Authority based on their Index of Multiple Deprivation 2007 (IMD 2007) deprivation score, and then grouping the LSOAs in each Local Authority into five groups (quintiles) with approximately equal numbers of LSOAs in each. The upper local deprivation quintile (Quintile 1) corresponds with the 20% most deprived small areas within that Local Authority. The mortality rates have been directly age-standardised using the European Standard Population in order to make allowances for differences in the age structure of populations. There are inequalities in health. For example, people living in more deprived areas tend to have shorter life expectancy, and higher prevalence and mortality rates of most cancers. Lung cancer accounts for 7% of all deaths among men and in England every year and 4% of deaths among women every year. This amounts to 24% of all cancer deaths among men in England and 18% of all cancer deaths among women in England1. Reducing inequalities in premature mortality from all cancers is a national priority, as set out in the Department of Health’s Vital Signs Operating Framework 2008/09-2010/111. This indicator has been produced in order to quantify inequalities in lung cancer mortality by deprivation. This indicator has been discontinued and so there will be no further updates. Legacy unique identifier: P01406

Legacy unique identifier: P00508

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Summary statistics of lung cancer incidence rates for Whites in 8 U.S. geographic regions, 1999–2012 (cases per 100,000).

This dataset contains Cancer Incidence data for Lung Cancer (All Stages^) including: Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2016 to 2020.Data are segmented by sex (Both Sexes, Male, and Female) and age (All Ages, Ages Under 50, Ages 50 & Over, Ages Under 65, and Ages 65 & Over), with field names and aliases describing the sex and age group tabulated.For more information, visit statecancerprofiles.cancer.govData NotationsState Cancer Registries may provide more current or more local data.TrendRising when 95% confidence interval of average annual percent change is above 0.Stable when 95% confidence interval of average annual percent change includes 0.Falling when 95% confidence interval of average annual percent change is below 0.† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.‡ Incidence Trend data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.Rates and trends are computed using different standards for malignancy. For more information see malignant.^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.Data Source Field Key(1) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(5) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(6) Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).(7) Source: SEER November 2022 submission.(8) Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2022 data.Some data are not available, see Data Not Available for combinations of geography, cancer site, age, and race/ethnicity.Data for the United States does not include data from Nevada.Data for the United States does not include Puerto Rico.

Deaths from lung cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

For 2023, it was estimated that there would be 25 new lung cancer cases among those between aged 15 to 29 years old. Cancer is one of the leading causes of premature death in Canada. This statistic displays the estimated number of new lung cancer cases in Canada by age group in 2023.

Lung Cancer Deaths reports the number, crude rate, and age-adjusted mortality rate (AAMR) of deaths due to lung cancer.

Number of new cases and age-standardized rates of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Death rate has been age-adjusted by the 2000 U.S. standard population. Single-year data are only available for Los Angeles County overall, Service Planning Areas, Supervisorial Districts, City of Los Angeles overall, and City of Los Angeles Council Districts.Lung cancer is a leading cause of cancer-related death in the US. People who smoke have the greatest risk of lung cancer, though lung cancer can also occur in people who have never smoked. Most cases are due to long-term tobacco smoking or exposure to secondhand tobacco smoke. Cities and communities can take an active role in curbing tobacco use and reducing lung cancer by adopting policies to regulate tobacco retail; reducing exposure to secondhand smoke in outdoor public spaces, such as parks, restaurants, or in multi-unit housing; and improving access to tobacco cessation programs and other preventive services.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.

Summary statistics of lung cancer incidence rates for Blacks and Whites in 8 U.S. Geographic Regions, 1999–2012 (cases per 100,000).

This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.

As of 2022, the age-standardized mortality rate of lung cancer worldwide was 16.8 per 100,000 population. At this time, the mortality rate of lung cancer was highest in Polynesia. This statistic shows the age-standardized mortality rate of lung cancer worldwide as of 2022, by region.

Summary statistics for lung cancer incidence rates in the Mid-South states, 1999–2012 (cases per 100,000).

Data Showing - Age rates of lung cancer incidence - Plymouth - 2009 - 2013